中國衛生(00673.HK)訂立諒解備忘錄 投資最多3,000萬人幣在健康基金
中國衛生集團(00673.HK)公布,與北京博偉智信投資管理就戰略合作訂立不具約束力之諒解備忘錄,公司擬作為有限合夥人投資最多3,000萬元人民幣於待由普通合夥人創立及管理的基金,如該基金有意變現其投資項目,公司將享有有關項目的優先購買權,並以心血管疾病相關項目優先。普通合夥人亦將進一步與公司開展合作,以於製藥及醫療行業成立其他基金及物色投資機遇,及公司之潛在戰略投資者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.